Functionalized Solid-Sphere PEG-b-PCL Nanoparticles to Target Brain Capillary Endothelial Cells In Vitro

Published on Jun 1, 2016in Journal of Nanomaterials1.98
· DOI :10.1155/2016/7818501
Philip Grossen8
Estimated H-index: 8
(University of Basel),
Gabriela Québatte6
Estimated H-index: 6
(University of Basel)
+ 3 AuthorsJörg Huwyler49
Estimated H-index: 49
(University of Basel)
Nanoparticles are increasingly used to implement drug targeting strategies. In the present study, solid-sphere nanoparticles (SNPs) made of poly(ethylene glycol)-b-poly(ź-caprolactone) (PEG-b-PCL) were covalently linked to a monoclonal antibody (83-14źmAb) targeted against the human insulin receptor that is highly expressed on human brain microvascular endothelial cells. Resulting targeted SNPs were characterized using transmission electron microscopy (TEM), cryo-TEM, dynamic light scattering, and fluorescence correlation spectroscopy. The critical aggregation concentration was determined using a fluorescence approach. Interaction with a well-characterized human in vitro model of the blood-brain barrier (hCMEC/D3) was analysed using an array of methods (flow cytometry, confocal laser scanning microscopy, and TEM). The toxicity on hCMEC/D3 cells and in addition on the human liver cell line HepG2 was assessed using the MTT assay. SNPs with a diameter of 80źnm and a homogeneous size distribution were obtained. Successful conjugation of 83-14źmAb using a heterobifunctional linker resulted in 5-6 molecules of fluorescently labeled 83-14źmAb per SNP. Functionalized SNPs were taken up by hCMEC/D3 cells efficiently without showing a significant toxic effect on cells of the blood-brain barrier and HepG2 cells. These results indicate that functionalized PEG-b-PCL SNPs are a promising candidate to deliver drugs to the CNS.
📖 Papers frequently viewed together
944 Citations
4 Authors (Moataz Mekawy, ..., Teiji Tominaga)
6 Citations
332 Citations
#1Eain M. Cornford (WLAC: West Los Angeles College)H-Index: 14
#1Eain M. Cornford (UCLA: University of California, Los Angeles)H-Index: 23
Last. William M. Pardridge (UCLA: University of California, Los Angeles)H-Index: 134
view all 10 authors...
AbstractResearch was undertaken to establish transplacental delivery of active genes to fetal brain by a non-viral vector, antibody-specific targeted therapeutic procedure. PEGylated immunoliposomes (PILs) containing firefly luciferase DNA under the influence of the SV40 promoter injected intravenously into near-term pregnant mice produced luminometric evidence of CNS tissue luciferase activity at 48-h post-injection in all newborn pups. In utero delivery of this pGL3 DNA was shown after a singl...
11 CitationsSource
#1Helene Kettiger (University of Basel)H-Index: 8
#2Didem Sen Karaman (Åbo Akademi University)H-Index: 6
Last. Joerg Huwyler (University of Basel)H-Index: 15
view all 5 authors...
Abstract Purpose Silica nanoparticles (SNPs) are increasingly used as drug delivery systems (DDS) and for biomedical imaging. Therapeutic and diagnostic agents can be incorporated into the silica matrix to improve the stability and dissolution of drug substances in biological systems. However, the safety of SNPs as drug carriers remains controversial. To date, no validated and accepted nano-specific tests exist to predict the potentially harmful impact of these materials on the human body. Metho...
24 CitationsSource
#1Ana Rute Neves (University of Porto)H-Index: 17
#2Joana Fontes Queiroz (University of Porto)H-Index: 6
Last. Salette Reis (University of Porto)H-Index: 58
view all 6 authors...
Nanotechnology can be an important tool to improve the permeability of some drugs for the blood–brain barrier. In this work we created a new system to enter the brain by functionalizing solid lipid nanoparticles with apolipoprotein E, aiming to enhance their binding to low-density lipoprotein receptors on the blood–brain barrier endothelial cells. Solid lipid nanoparticles were successfully functionalized with apolipoprotein E using two distinct strategies that took advantage of the strong inter...
55 CitationsSource
#1Tomaž Einfalt (University of Basel)H-Index: 2
#2Roland Goers (University of Basel)H-Index: 6
Last. Cornelia G. Palivan (University of Basel)H-Index: 36
view all 7 authors...
The development of advanced stimuli-responsive systems for medicine, catalysis, or technology requires compartmentalized reaction spaces with triggered activity. Only very few stimuli-responsive systems preserve the compartment architecture, and none allows a triggered activity in situ. We present here a biomimetic strategy to molecular transmembrane transport by engineering synthetic membranes equipped with channel proteins so that they are stimuli-responsive. Nanoreactors with triggered activi...
48 CitationsSource
#1Regina Bleul (ZEISS: Carl Zeiss AG)H-Index: 1
#1Regina BleulH-Index: 3
Last. Michael Maskos (University of Mainz)H-Index: 27
view all 3 authors...
Polymersomes as synthetic analogues of liposomes appear frequently in relevant literature as promising candidates for a wide range of different applications including drug delivery, theranostic multitools, and nanoreactors. In particular, as nanotransporters for nanomedical applications in vivo, requirements concerning the reproducible manufacturing and reliable size control are extremely high. This Perspective highlights the importance of size control especially in the context of nanomedicine a...
83 CitationsSource
#1Dominik Witzigmann (University of Basel)H-Index: 16
#2Sandro Sieber (University of Basel)H-Index: 9
Last. Jörg Huwyler (University of Basel)H-Index: 49
view all 9 authors...
Nanocarriers encapsulating gold nanoparticles (AuNPs) hold tremendous promise for numerous biomedical applications. So far only a few fabrication strategies have been investigated and efficient processes for the manufacturing of gold nanohybrids (AuNHybs) are still missing. We encapsulated a tetrachloroaurate/citrate mixture within nanocarriers and initiated the AuNP formation after self-assembly of the nanomaterial by a temperature shift. This nanoreactor approach was successfully combined with...
13 CitationsSource
#1Xiaohe Tian (UCL: University College London)H-Index: 23
#2Sophie Nyberg (UCL: University College London)H-Index: 7
Last. Giuseppe Battaglia (UCL: University College London)H-Index: 55
view all 11 authors...
The blood-brain barrier (BBB) is by far the most important target in developing new approaches to improve delivery of drugs and diagnostic tools into the Central Nervous System (CNS). Here we report the engineering of pH- sensitive polymersomes (synthetic vesicles formed by amphiphilic copolymers) that exploit endogenous transport mechanisms to traverse the BBB, enabling delivery of large macromolecules into both the CNS parenchyma and CNS cells. We achieve this by targeting the Low Density Lipo...
93 CitationsSource
#1Andreas Wicki (University Hospital of Basel)H-Index: 3
#1Andreas Wicki (University Hospital of Basel)H-Index: 17
Last. Jörg Huwyler (University of Basel)H-Index: 49
view all 4 authors...
Cancer is a leading cause of death worldwide. Currently available therapies are inadequate and spur demand for improved technologies. Rapid growth in nanotechnology towards the development of nanomedicine products holds great promise to improve therapeutic strategies against cancer. Nanomedicine products represent an opportunity to achieve sophisticated targeting strategies and multi-functionality. They can improve the pharmacokinetic and pharmacodynamic profiles of conventional therapeutics and...
944 CitationsSource
#1Dong Ye (UCD: University College Dublin)H-Index: 7
#2Kenneth A. Dawson (UCD: University College Dublin)H-Index: 90
Last. Iseult Lynch (University of Birmingham)H-Index: 68
view all 3 authors...
We report here a protocol to characterise and monitor the quality of in vitro human cellular barrier models using Transmission Electron Microscopy (TEM), which can be applied for transport assays, mechanistic studies and screening of drug/compound (including nanoparticle) penetration across such biological barriers. Data from two examples of biological barriers are given, namely the hCMEC/D3 endothelial blood–brain barrier model, and the Caco-2 intestinal epithelial barrier model, to show the ge...
37 CitationsSource
#1Hisataka Kobayashi (NIH: National Institutes of Health)H-Index: 80
#2Baris TurkbeyH-Index: 76
Last. Peter L. ChoykeH-Index: 140
view all 4 authors...
In order to efficiently deliver anticancer agents to tumors, biocompatible nanoparticles or bioconjugates, including antibody–drug conjugates (ADCs), have recently been designed, synthesized, and tested, some even in clinical trials. Controlled delivery can be enhanced by changing specific design characteristics of the bioconjugate such as its size, the nature of the payload, and the surface features. The delivery of macromolecular drugs to cancers largely relies on the leaky nature of the tumor...
49 CitationsSource
Cited By9
#1Tomáš UrbánekH-Index: 2
#1Tomáš Urbánek (CAS: Academy of Sciences of the Czech Republic)H-Index: 17
Last. Martin HrubýH-Index: 18
view all 9 authors...
Polymeric drug carriers exhibit excellent properties that advance drug delivery systems. In particular, carriers based on poly(ethylene oxide)-block-poly(epsilon-caprolactone) are very useful in pharmacokinetics. In addition to their proven biocompatibility, there are several requirements for the efficacy of the polymeric drug carriers after internalization, e.g., nanoparticle behavior, cellular uptake, the rate of degradation, and cellular localization. The introduction of gamma-butyrolactone u...
3 CitationsSource
#1Daniel Ehrsam (University of Basel)H-Index: 2
#2Sandro Sieber (University of Basel)H-Index: 9
Last. Henriette E. Meyer zu Schwabedissen (University of Basel)H-Index: 31
view all 7 authors...
The concept of triggered drug release offers a possibility to overcome the toxic side effects of chemotherapeutics in cancer treatment by reducing systemic exposure to the active drug. In the present work, the concept forsees the use of the extracellular enzyme MMP9 as an enzymatic trigger for drug release in the proximity of tumor cells. Methods: A paclitaxel-hemisuccinate-peptide conjugate as a building block for self-assembling nanoparticles was synthesized using standard conjugation approach...
#1Daniel Ehrsam (University of Basel)H-Index: 2
#2Fabiola Porta (University of Basel)H-Index: 9
Last. Henriette E. Meyer zu Schwabedissen (University of Basel)H-Index: 31
view all 5 authors...
Background: It was our intention to develop cathepsin B-sensitive nanoparticles for tumor-site-directed release. These nanoparticles should be able to release their payload as close to the tumor site with a decrease of off-target effects in mind. Cathepsin B, a lysosomal cysteine protease, is associated with premalignant lesions and invasive stages of cancer. Previous studies have shown cathepsin B in lysosomes and in the extracellular matrix. Therefore, this enzyme qualifies as a trigger for su...
3 CitationsSource
#1Alysia Cox (University of Milano-Bicocca)H-Index: 5
#2Daniele Vinciguerra (CNRS: Centre national de la recherche scientifique)H-Index: 6
Last. Julien Nicolas (CNRS: Centre national de la recherche scientifique)H-Index: 53
view all 8 authors...
Abstract Nanoparticles may provide a viable way for neuroprotective drugs to cross the blood–brain barrier (BBB), which limits the passage of most drugs from the peripheral circulation to the brain. Heterotelechelic polymer prodrugs comprising a neuroprotective model drug (adenosine) and a maleimide functionality were synthesized by the “ drug-initiated ” approach and subsequent nitroxide exchange reaction. Nanoparticles were obtained by nanoprecipitation and exhibited high colloidal stability w...
10 CitationsSource
Nanomedicine is a constantly expanding field, facilitating and improving diagnosis and treatment of diseases. As nanomaterials are foreign objects, careful evaluation of their toxicological and functional aspects prior to medical application is imperative. In this study, we aimed to determine the effects of gold and polymer-coated silica nanoparticles used in laser tissue soldering on brain endothelial cells and the blood–brain barrier using rat brain capillary endothelial cells (rBCEC4). All ty...
5 CitationsSource
#1Sandro Sieber (University of Basel)H-Index: 9
#2Philip Grossen (University of Basel)H-Index: 8
Last. Jörg Huwyler (University of Basel)H-Index: 49
view all 7 authors...
Abstract Macrophage recognition of nanoparticles is highly influenced by particle size and surface modification. Due to the lack of appropriate in vivo screening models, it is still challenging and time-consuming to characterize and optimize nanomedicines regarding this undesired clearance mechanism. Therefore, we validate zebrafish embryos as an emerging vertebrate screening tool to assess the macrophage sequestration of surface modified particulate formulations with varying particle size under...
21 CitationsSource
#1Sandro Sieber (University of Basel)H-Index: 9
#2Philip Grossen (University of Basel)H-Index: 8
Last. Jörg Huwyler (University of Basel)H-Index: 49
view all 7 authors...
Abstract The interactions of nanomedicines with biological environments is heavily influenced by their physicochemical properties. Formulation design and optimization are therefore key steps towards successful nanomedicine development. Unfortunately, detailed assessment of nanomedicine formulations, at a macromolecular level, in rodents is severely limited by the restricted imaging possibilities within these animals. Moreover, rodent in vivo studies are time consuming and expensive, limiting the...
38 CitationsSource
Abstract Despite the outstanding progress in modern medicine, the oral delivery of peptide drugs is limited until today due to their instability in the gastrointestinal tract and low mucosa penetration. To overcome these hurdles, liposomes containing the specific tetraether lipid GCTE (glycerylcaldityltetraether lipid) were examined. For this purpose, the glycopeptide antibiotic vancomycin was used as model substance and liposomes were prepared by DAC (dual assymetric centrifugation). These lipo...
37 CitationsSource
#1Klara Kiene (University of Basel)H-Index: 3
#2Susanne H. Schenk (University of Basel)H-Index: 8
Last. Jörg Huwyler (University of Basel)H-Index: 49
view all 7 authors...
Abstract Nanoparticles, such as polymersomes, can be directed to the hepatic asialoglycoprotein receptor to achieve targeted drug delivery. In this study, we prepared asialofetuin conjugated polymersomes based on the amphiphilic di-block copolymer poly(dimethylsiloxane)- b -poly(2-methyloxazoline) (PDMS- b -PMOXA). They had an average diameter of 150 nm and formed monodisperse vesicles. Drug encapsulation and sustained release was monitored using the hydrophilic model compound carboxyfluorescein...
16 CitationsSource
#1Philip Grossen (University of Basel)H-Index: 8
#2Dominik Witzigmann (University of Basel)H-Index: 16
Last. Jörg Huwyler (University of Basel)H-Index: 49
view all 4 authors...
The lack of efficient therapeutic options for many severe disorders including cancer spurs demand for improved drug delivery technologies. Nanoscale drug delivery systems based on poly(ethylene glycol)-poly(e-caprolactone) copolymers (PEG-PCL) represent a strategy to implement therapies with enhanced drug accumulation at the site of action and decreased off-target effects. In this review, we discuss state-of-the-art nanomedicines based on PEG-PCL that have been investigated in a preclinical sett...
168 CitationsSource